3 бет - Ең жақсы урологияның урологтар - ЖОҒ-261 дәрігерлер

Dr. Daniel Waclawski

Specialist in urology

His experience spans the fields of general surgery and urology, gained through many years of practice in the treatment of urinary tract disorders.

Scope of work:

Dr Waclawski offers specialist consultations in urology, performs ultrasound examinations and carries out a range of surgical procedures, including, but not limited to, surgery for stool and excision of periurethral cysts and urethral meatus.

Diseases treated:

Urinary incontinence

Polyps

Kidney, ureter and bladder stones

Benign prostatic hyperplasia

Urethral strictures

Inflammation of the urinary tract, prostatitis, testicular inflammation, etc.

Мүшеліктер

• Еуропалық Урология Қауымдастығы (EAU)
• Венгриялық Урологтар Қоғамы
• Венгрия Медициналық Палатасы

Ғылыми дәрежесі

Ph.D

Халықаралық тәжірибе

• 2011.11: Лапароскопиялық урологиялық хирургияның жетілдірілген курсы - Лейпциг Университеттік Клиникасы, Урология Бөлімі, Лейпциг, Германия
• 2011.12: Урологияның Еуропалық Қоғамының 2 апталық клиникалық іссапары, Урология Бөлімі, Орхус Университеттік Ауруханасы Скейбю, Орхус, Дания
• 2013.02. - 2013.05.: Урологияның Еуропалық Қоғамының 3 айлық зерттеу шәкіртақысы;
• 2013.09. - 2014.09.: Урологияның Еуропалық Қоғамының 1 жылдық зерттеу шәкіртақысы
  • Лунд Университеті, Зертханалық Медицина Институты, Микробиология, Иммунология және Гликобиология Бөлімі, Лунд, Швеция;
  • Микробиология, Иммунология және Гликобиология Бөлімі, Зертханалық Медицина Институты, Лунд Университеті, Лунд, Швеция

Dr. Teanchai Siricharoensang spent 13 years as a senior Urologist at Samitivej Hospital Bangkok.

Having attended Siriraj medical school and Mahidol University, Dr. Chai is an Advanced laparoscopic surgeon and an endoscopic and urologist surgeon.

Certified ultrasonic lipolysis and certified anti-aging specialist and a member of the American Urological Association.

Dr. Ozden Gul is a general surgeon trained at Istanbul University Cerrahpaşa Faculty of Medicine. She completed her general surgery residency at Haydarpaşa Numune Training and Research Hospital. She has decades of surgical experience and is fluent in English.

Her practice includes gastrointestinal surgery (gallbladder disease, hernias, appendicitis, GI disorders). She also treats endocrine conditions (thyroid, parathyroid, adrenal) and breast disease, both benign and malignant. She manages emergency and trauma cases. She offers minimally invasive laparoscopic surgery.

She has worked at Haydarpaşa Numune, Bakırköy, Taksim First Aid, Uzunköprü State, Keşan State, Beykoz Medical Center, and Medivia Hospital. She is known for meticulous technique and patient-centered care.

Education and Expertise

• 1992-1997 ULUDAĞ UNIVERSITY FACULTY OF MEDICINE
• 1998 – 2003 1998 – 2003 IZMIR ATATURK TRAINING AND RESEARCH HOSPITAL UROLOGY CLINIC
• 2018-2023 IZMIR UNIVERSITY OF ECONOMICS UROLOGY CLINIC

Diseases

• Kidney Cancer
• Bladder Cancer
• Prostate
• Prostate Cancer

Treatment Methods

• Kidney Stone Treatment
• Endoscopic Stone Surgery-Flexible URS
• Greenlight
• HoLEP-ThuLEP
• Laparoscopic Radical Prostatectomy
• Laparoscopic Radical-Partial Nephrectomy
• Percutaneous Stone Surgery Mini-Micro PCNL
• Plasmakinetic Vaporization
• Radical prostatectomy
• Radical Cystectomy and Neobladder
• R.I.R.S.
• Robotic Surgery
• TUR-Bladder
• RADISH

Experience

• Assist.Dr. Izmir Ataturk Training and Research Hospital 1998-2003
• Specialist Dr. Izmir Basmane Healing Hospital 2004-2013
• Assoc. Prof. Dr. Izmir Basmane Şifa Hospital, Şifa University Faculty of Medicine 2013-2016
• Assoc. Prof. Dr. Medical Park Izmir Hospital, Izmir University Faculty of Medicine 2016-2016
• Specialist Dr. Medical Park Izmir Hospital 2016-2018
• Assoc. Prof. Dr. Medical Point Hospital, Izmir University of Economics 2018-2023

Professional Memberships

• American Society Of Clinical Oncology
• European Association Of Urology
• European Society For Medical Oncology
• American Society For Radiation Oncology
• European Society For Radiotherapy And Oncology
• European Society Of Surgical Oncology
• International Society Of Geriatric Oncology
• American Association For Cancer Research
• European Association For Cancer Research
• Urological Association of Asia
• Turkish Urology Association
• Turkish Andrology Association
• Endourology Association
•  

In his professional career, Dr. Sarıer began working as a urology specialist at Özel Antalya Yaşam Hospital from 2005 to 2008, and then served at Gümüşsuyu Asker Hospital between 2008 and 2009. Since 2009, he has been employed at Medical Park Antalya Hospital, where he received the title of associate professor in 2020. Additionally, he served as a faculty member in the Department of Urology at Altınbaş University Faculty of Medicine from 2016 to 2017, and has been continuing his academic career as a faculty member in the Department of Urology at İstinye University Faculty of Medicine since 2021.

Eduardo Fernandez, MD

Medical Doctor & Stem Cell Expert

Dr. Eduardo Fernandez is a distinguished medical professional specializing in stem cell therapies and regenerative medicine. He is a certified member of the Mexican College of Stem Cells and Regenerative Medicine, as well as the Mexican Council of Stem Cells for Therapeutic and Research Purposes. Dr. Fernandez’s certifications are the result of a rigorous 8-hour examination process, reserved for a select group of doctors who possess advanced knowledge and experience in these cutting-edge treatments. With only 50 certified doctors in Mexico, Dr. Fernandez’s expertise is highly sought after and respected.

In addition to his national recognition, Dr. Fernandez is awaiting international certification from the renowned International Society for Stem Cell Research (ISSCR). Membership in this prestigious organization signifies Dr. Fernandez’s extensive experience and expertise in stem cell treatments. The ISSCR includes prominent scientists from renowned universities such as Harvard, Yale, Stanford, and other esteemed institutions worldwide. Being a part of this elite society represents the pinnacle of honor and prestige in the field of stem cell therapies.

Furthermore, Dr. Fernandez is also seeking membership and international certification from the International Society for Extracellular Vesicles (ISEV), the largest community of extracellular vesicle researchers globally. With only two thousand members worldwide, ISEV’s select nature underscores Dr. Fernandez’s exceptional dedication to advancing scientific knowledge in the study of exosomes and cellular messengers. By pursuing membership in ISEV, Dr. Fernandez continues to demonstrate his commitment to staying at the forefront of research and innovation in the field of regenerative medicine.

Education and Specialization

• Bachelor’s & Master’s Degree: Akdeniz University Faculty of Medicine, 1990 /1996
• Ph.D. / Medical Specialization: Urology, Akdeniz University, 1997/2002
• Associate Professor / Professor: Urology, Harran University, 2012/ 2013
• Professor: Urology, Istanbul Gelişim University, Faculty of Health Sciences, 2019/ 2023

Professional Experience

• Research Assistant: Akdeniz University Faculty of Medicine, Department of Urology, Antalya (1997/ 2002)
• Urology Specialist: Akdeniz University Faculty of Medicine, Department of Urology, Antalya (March 2002 / October 2002)
• Lecturer: Harran University Faculty of Medicine, Department of Urology, Şanlıurfa (2003/ 2006)
• Assistant Professor: Harran University Faculty of Medicine, Department of Urology, Şanlıurfa (2006 / 2010)
• Associate Professor: Harran University Faculty of Medicine, Department of Urology, Şanlıurfa (2012 /2013)
• Associate Professor: Ministry of Health Antalya Training and Research Hospital, Urology Clinic, Antalya (2013 /2018)
• Associate Professor: Memorial Antalya Hospital, Urology Clinic, Antalya (2018 /2019)
• Professor: Memorial Antalya Hospital, Urology Clinic, Antalya & Istanbul Gelişim University, Faculty of Health Sciences (2019/ 2023)
• Professor: Medical Park Antalya Hospital Complex (2023 / Present)

International Experience

• Berlin University, Charité Hospital – Fellowship in Urology (February 1 - March 31, 2006, Berlin, Germany)
• Akdeniz University Faculty of Medicine, Urology Clinic – Postgraduate Education in Laparoscopic Surgery by Endourology Association (May 1 - June 12, 2008, Antalya, Turkey)

Memberships in Scientific Organizations

• Turkish Urology Association
• Turkish Andrology Association
• Turkish Endourology Association
• Turkish Medical Association
• European Association of Urology
• Endourological Society
• Urological Surgery Association
• Eurasian Urooncology Association
• Turkish Pediatric Urology Association
•  
• TÜYK Competency Certificate
• "Recent Advances in Laparoscopic Urology" & "Urodynamics and Neuro-Uropharmacology" (October 8, 2000, Izmir)
• IRCAD Advanced Laparoscopic Urology Course Certificate (February 13-15, 2008)
• Laparoscopic Training Program Certificate (Endourology Association, 2008, Antalya)
• Experimental Animal Usage Certificate (January 26 - February 4, 2009)

Head of Teaching at the Puerto Vallarta Regional Hospital

2020-2023

Medical records manager at the Regional Hospital of Puerto Vallarta 2 months 2020

General practitioner in private medical office

2015-2022

Doctor in charge of weight control clinic

2013-2014

Medical assistant in dermatology clinic

2008-2013

Medical Assistant in Dermatological procedures.

 Medical Assistant in minimally invasive surgical procedures

 Operation of fractional laser machine - IPIXEL-ER and

facial rejuvenation with IPL.

 Experience in laser hair removal with Intense Pulsed Light and

radiofrequency

 Experience with ultrasonic cavitation

 Experience with ultraviolet (UV) light phototherapy machine for the

treatment of psoriasis and vitiligo.

 Experience assisting in Botox and Fillers procedures.

 Biomagnet certified by the Higher Institute of Biomagnetism

doctor ISAAC GOIZ DURAN

 Experience in clinical records

 Training in continuing education and professional development of teachers

Education/Academic Experience

Apr 1995 – Oct 2001                Medical School of Aristotle University of Thessaloniki, Greece

Mar 2007                                   IELTS Certificate (Overall Band Score 7.5)

Feb 2011                                    CCST in Urology, Aristotle University of Thessaloniki, Greece

June 2012                                  Fellow of the European Board of Urology (FEBU)

Sept 2014                                  Fellow in Andrology/Reconstructive Surgery (Mr Giulio Garaffa,         UCLH / Mid-Essex)

Apr 2016                                   Fellow of the Royal College of Surgeons of England (FRCS Eng)

Oct 2018                                   Honorary Senior Lecturer St Andrews University

Sep 2019                                   Urology ChM Tutor in Andrology and Minimally Invasive Surgery (MIMS) University of Edinburgh

Aug 2020                                  European Union Expert Panel Member of in vitro Medical Devices (EU EXPAMED)

Current and Previous appointments

Current appointment

May 2022- Present         Consultant Urologist German Oncology Centre, Limassol, Cyprus

Previous appointments

Nov16- May 2021       Consultant Urological Surgeon Victoria/ Queen Margaret Hospital Fife, Scotland.

Nov 2012 - Oct 2016      Consultant Urologist Broomfield Hospital, Mid-Essex Hospitals Trust 

Jan 2011 - Oct 2012      Urology Clinical Research Fellow, Spelialist Registrar Level), Bristol Royal Infirmary, United Bristol Hospitals Trust

Dec 2009 -Dec 2010      Urology Resident G. Gennimatas Hospital, Aristotle University of Thessaloniki

Duties

• Performing routine and major Penile / Urethral Reconstruction as well as Core Urology procedures twice weekly at Victoria and Queen Margaret Hospitals (Green light prostatectomy, Urolift Service lead, Prostate template biopsies, General urology)

Consultant Urologist providing and supervising the services of andrology and urethral reconstruction surgery. Also covering a general urology one stop outpatient clinics three times per week (Victoria and Queen Margaret Hospitals).

Participation in once weekly local cancer and once monthly specialist male uro-genital reconstruction MDT meetings (Honorary contract at the Western General Hospital, Edinburgh) as well as grand ward rounds.

Undergraduate student trainer and member of examiners panel at St Andrews University, Scotland.

Participation in 1:9 on call Urology Consultant rota.

Research

• Victoria Hospital, Kirkcaldy (NHS Fife) lead investigator. A prospective, multicentre study with subgroup randomisation into MRI-U/S image fusion guided prostate biopsies and routine transrectal U/S guided biopsies.  (MULTIPROS Study)
•  
• Broomfield Hospital (MEHT) sub-investigator. A pragmatic multicentre randomised superiority trial of open urethroplasty versus endoscopic urethrotomy. (OPEN Study)
•  
• Broomfield Hospital (MEHT) sub-investigator. A Multicentre randomised controlled trial of extracorporeal shockwave lithotripsy, as first treatment option, compared with direct progression to ureteroscopic treatment, for ureteric stones. (TISU
• Study)
•  
• Bristol Royal Infirmary sub-investigator. A Multicentre Randomised Controlled Trial of the Use of Drug Therapy in the Management of Symptomatic Ureteric Stones in Hospitalised Patients. (SUSPEND Study)
•  
• Bristol Royal Infirmary sub-investigator. A Multicentre Prospective Single Arm Intervention Trial Evaluating Focal Therapy using High Intensity Focused Ultrasound (Sonablate 500) for Localised Prostate Cancer. (HIFU INDEX Study)
•  
• Bristol Royal Infirmary sub-investigator, A Randomised Controlled Trial to Determine the Effect of Decapeptyl on Reduction of Prostate Volume Pre-Radiotherapy Compared with Standard Therapy (Zoladex). (EDVART Study)

Teaching Experience

Fife Simulation BPH Course Fascilitator (Scottish Urology Training Programme, Queen Margaret Hospital, Dumfermline Fife)

Urology Simulation boot camp Faculty member (St James's University Hospital, Leeds)

General Practitioner Urology Training Programme Fascilitator (ScotGem)

Objective Structured Clinical Examination (OSCE) assessor (St Andrews University Medical School)

Teaching (case-based discussions) and trainee supervision in theatres (East Anglia / East of   Scotland Deaneries trainees)

FY1 Doctors Urology teaching Bristol Royal Infirmary (University Bristol Hospitals Trust)

Undergraduate teaching of medical students in General Hospital of the city of Drama, Greece

Anatomy, Physiology and First Aid to Undergraduate nursing students

Dr. Haluk Inal is a urologic surgeon. He graduated from the GATA Faculty of Medicine. He completed his specialty training in urology at Haydarpaşa GATA Training and Research Hospital. He has decades of clinical and surgical experience. He provides advanced, minimally invasive urologic care.

Expertise: endourology (kidney stones, ureteral obstruction, urinary tract problems); prostate disease (BPH, prostate cancer); urologic oncology (kidney, bladder, testicular cancers); andrology and male health (erectile dysfunction, infertility); pediatric urology (undescended testis, hypospadias, congenital anomalies). He is known for precise, safe, and patient-focused care.

Education:

1997 – 2003    Hacettepe University

2004 – 2009     Ankara Dışkapı Training and Research Hospital

2016 – 2019     Afyon Kocatepe University

Experience:

2022 – Still       Lokman Hekim Akay Hospital

2019 – 2022     Private Meddem Hospital

2018 – 2019      Afyon Kocatepe University

2015 – 2018      Afyon Kocatepe University

2012 – 2015      Bozok University Faculty of Medicine

2010 – 2012     Ankara Dışkapı Training and Research Hospital

2009 – 2010      TSK Rehabilitation and Care Center Presidency

2004 – 2009     Ankara Dışkapı Training and Research Hospital

Dr. George Tie is an expert in minimally invasive urological surgery. He manages kidney stones and performs advanced prostate procedures, including TURP and laser surgery. He also treats urologic cancers using laparoscopic, endoscopic, and robotic techniques.

Dr. Tie is known for his high success rates and precise surgical skills. He focuses on patient comfort and fast recovery. He provides evidence-based care to international patients in a modern setting, ensuring advanced and reliable urological treatment.

Dr. Ayan graduated from Medical School in 1991 and completed his urology education in 1997. At the beginning of his carrier, he was a post doctorate research fellow at the Department of Urology of Harvard Medical School, Children’s Hospital in Boston (1999-2000). He studied the effect of partial ureteral obstruction to the kidney in early developmental stage in an experimental animal fetus model. This study provided a significant contribution to a complicated issue of pediatric urology and was cited many times by its successors. 

He became associate professor of urology in 2004 and was appointed as a professor of urology in 2009. He was accepted as a clinical fellow in Minimal Invasive Urologic Oncology at the Department of Surgery, Section of Urology at the University of Chicago (2014-2015). He worked in an intense oncology program mainly concentrated on robotic surgery of prostate and kidney cancer. Because of this background, he is mainly interested in urologic oncology and pediatric urology. The primary portion of his daily practice consist of kidney cancer, prostate cancer, bladder cancer, neonatal hydronephrosis, ureteropelvic junction obstruction, urine reflux to kidney, hypospadias and undescended testis. 

Because of its prevalence in Turkey, Prof. Ayan has a huge experience with urinary stone disease and he is doing large number of endoscopic and percutaneous surgeries for kidney, ureter and bladder stones. 

Prof. Ayan holds United States Medical License and European Board of Urology Certificate. He is a member of AUA, EAU and Turkish Urologic Surgery and Urologic Oncology Societies. 

List of International Scientific Publications; 

1. Ayan S, Yildirim S, Ucar C, Sarioglu Y, Gültekin EY, Butuner C. Corporal reactivity to adenosine and prostaglandin E1 in alloxan-induced diabetic rabbit corpus cavernosum and the effect of insulin therapy. BJU Int, 83: 108-12, 1999. 

2. Yildirim S, Ayan S, Sarioglu Y, Gültekin EY, Butuner C. The effects of long-term oral administration of L-arginine on the erectile response of rabbits with alloxan-induced diabetes. BJU Int, 83: 679-85, 1999. 

3. Ayan S, Kaloglu C, Gökce G, Kılıcarslan H, Gültekin EY. Effect of insulin therapy to diabetic cystopathy: urodynamic and histological findings in a rabbit model. Sc J Urol Nephrol, 33: 392-5, 1999. 

4. Yildirim S, Ayan S, Sarioglu Y, Gültekin Y, Uma S. Does diabetes mellitus affect the progress of tolerance to isosorbide dinitrate (ISDN) in corporal tissue? Nitric Oxide: Biology and Chemistry, 4: 29- 34, 2000. 

5. Ayan S, Sarioglu Y, Yildirim S, Gokce G, Bagcıvan I. Relaxation induced by omeprazole does not change in diabetic rabbit corpus cavernosum. BJU Int, 87(3):265-8, 2001. 

6. Ayan S, Gokce G, Kılıcarslan H, Kaya K, Gultekin EY. An unusual cause of urinary incon tinence: urethral coitus. Sc J Urol Nephrol, 35:254, 2001. 

7. Yildirim S, Simsek R, Ayan S, Gokce G, Sarıoğlu Y, Safak C. Relaxant effect of some benzothiazolinone dervatives on isolated rabbit corpus cavernosum. Urol Res, 29:182-5, 2001. 

8. Ayan S, Roth JA, Freeman MR, Bride SH, Peters C. Partial ureteral obstruction dysregulates the RAS in the fetal sheep. Urology, 58: 301-6, 2001. 

9. Kılıcarslan H, Ayan S, Gokce G, Kaya K, Gultekin EY. Cranial blind ending branch of a bifid ureter. Int Urol Nephrol, 32: 635-6, 2001. 

10. Gokce G, Kılıcarslan H, Ayan S, Yıldız E, Kaya K, Gultekin EY. Adenomatoid tumors of testis and epididym: a report of two cases. Int Urol Nephrol, 32:677-80, 2001. 

11. Ayan S, Gokce G, Kılıcarslan H, Ozdemir O, Yildiz E, Gultekin EY. K-RAS mutation in transitional cell carcinoma of urinary bladder. Int Urol Nephrol, 33:363-67, 2001. 

12. Bulut HE, Onarlıoglu B, Kaloglu C, Özdemir Ö, Ayan S. Effects of experimental diabetes and insulin treatment on rabbit renal morphology: a quantitative and qualitative study. Turk J Med Sci, 31: 209-16, 2001. 

13. Kılıcarslan H, Gokce G, Ayan S, Gultekin EY, Arıkan Y, Hocaoglu S. Fournier’s gangrene: a report of 20 cases. T Klin J Med Res 19:55-58, 2001. 

14. Gokce G, Kılıcarslan H, Ayan S, Tas F, Akar R, Kaya K, Gultekin EY. Genitourinary tuberculosis: A review of 174 cases. Scand J Infect Dis, 34: 338-40, 2002. 

15. Kilicarslan H, Yildirim S, Bagcivan I, Ayan S, Sarac B, Sarioglu Y. Effect of chronic renal failure (CRF) on purinergic responses of corpus cavernosal smooth muscle in rabbits. BJU Int 90(6):596-600, 2002. 

16. Bagcivan I, Gokce G, Ayan S, Yildirim S, Sarac B, Kilicarslan H, Sarioglu Y. Hydrogen-potassium ATPase inhibitors induce relaxation on rabbit prostatic strips in vitro.Int J Urol.;9(11):641-4; discussion 645, 2002. 

17. Bagcivan I, Kilicarslan H, Sarac B, Gokce G, Yildirim S, Ayan S, Sarioglu Y. The evaluation of the effects of renal failure on erectile dysfunction in a chronic renal failure (CRF) rabbit model. BJU Int.;91(7):697-701, 2003 

18. Kilicarslan H, Guvenal T, Ayan S, Gokce G, Cetin A, Gultekin Y. Comparison of outcomes of three different surgical techniques performed for stress urinary incontinence. Int J Urol.;10(3):126- 30, 2003. 

19. Kaya S, Poyraz O, Gökçe G, Kılıçarslan H, Kaya K and Ayan S. Role of Genital Mycoplasmata and Other Bacteria in Urolithiasis. Scand J Infect Dis, 35:315-317,2003. 

20. Kilicarslan H, Gokce G, Ayan S, Atalar M, Kaya S, Kaya K, Gultekin Y. A case of hydatid disease: urinary retention due to isolated retrovesical hydatid cyst in a boy. Scand J Infect Dis, 35 :408-410, 2003. 

21. Gokce G, Kaya K, Kılıcarslan H, Tas F, Ayan S, Yıldız E, Gultekin E Y. Epidermoid cyst in the renal pelvis. Int Urol Nephrol;35(1):9-10, 2003. 

22. Kilicarslan H, Gokce G, Ayan S, Guvenal T, Kaya K, Gultekin EY. Predictors of outcome after in situ anterior vaginal wall sling surgery. Int Urogynecol J Pelvic Floor Dysfunct ;14(5):339-41, 2003. 

23. Kilicarslan H, Gokce G, Kaya K, Ayan S, Gultekin YE. Surgical treatment of penil fractures. Ulus Travma Derg.;9(1):54-6, 2003. 

24. Yildiz E, Gokce G, Kilicarslan H, Ayan S, Goze F, Gultekin EY. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma. BJU Int. 2004 ;93(7):1087-93. 

25. Gokce G, Topsakal K, Ayan S, Kilicarslan H, Gokce SF, Gultekin EY. Case report: Nonobstructive giant urethral stone with two safety pins. Int Urol Nephrol. 2004;36(1):65-6. 

26. Kaya K, Ayan S, Gokce G, Kılıcarslan H, Yildiz E, Gultekin EY. Urinary nuclear matrix protein 22 for diagnosis of renal cell carcinoma. Scand J Urol Nephrol. 38 :1-5,2004. 

27. Ayan S, Kaya K, Topsakal K, Kılıçarslan H, Gokce G, Gültekin Y. Efficacy of tolterodine as a firstline treatment for non-neurogenic voiding dysfunction in children. BJU Int. 96(3):411-4, 2005. 

28. Kaya K, Gokce G , Kaya S, Kilicarslan H, Ayan S, Gultekin EY. Isolated renal and retropertoneal hydatid cysts: a report of 23 cases. Trop Doct. 2006 Oct;36(4):243-6. 

29. Candan F, Ayan S, Tas F, Gokce G, Elagoz S. Spontaneous renal laceration as the presenting feature of polyarteritis nodosa in a patient with familial Mediterranean fever after hepatitis A infection. Rheumatol Int, 25(6):475-7, 2005. 

30. Silig Y, Pinarbasi H, Gunes S, Ayan S, Bagci H, Cetinkaya O. Polymorphisms of CYP1A1, GSTM1, GSTT1, and prostate cancer risk in Turkish population. Cancer Invest, 24(1):41-5, 2006. 

31. Tanzer F, Ozgur A, Bardakci F, Cankorkmaz L, Ayan S. Analysis of a 1-year-old cystinuric patient with recurrent renal stones. Int J Urol. 13(10):1347-9, 2006. 

32. Kilicarslan H, Ayan S, Vuruskan H, Gokce G, Gultekin EY.Treatment of detrusor sphincter dyssynergia with baclofen and doxazosin. Int Urol Nephrol. 2006;38(3-4):537-41. 

33. Ayan S, Topsakal K, Gokce G, Gultekin EY.Efficacy of combined anticholinergic treatment and behavioral modification as a first line treatment for nonneurogenic and nonanatomical voiding dysfunction in children: a randomized controlled trial. J Urol. 2007 Jun;177(6):2325-8; discussion 2328-9. 

34. Ozdemir O, Gul E, Kilicarslan H, Gokce G, Beyaztas FY, Ayan S, Sezgin I.SRY and AZF gene variation in male infertility: a cytogenetic and molecular approach. Int Urol Nephrol. 2007;39(4):1183-9. 

35. Yildiz E, Ayan S, Goze F, Gokce G, Gultekin EY. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma. BJU Int. 2008 Mar;101(6):758-64. 

36. Kenan Kaygusuz, Gokhan Gokce, Iclal Ozdemir Kol, Semih Ayan and Sinan Gursoy. Efficacy of Preventive Analgesia with Tramadol or Lornoxicam for Percutaneous Nephrolithotomy: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study. Current Therapeutic Research 68(4), 205-216, 2007. 

37. Kaygusuz K, Gokce G, Gursoy S, Ayan S, Mimaroglu C, Gultekin Y.A comparison of sedation with dexmedetomidine or propofol during shockwave lithotripsy: a randomized controlled trial. Anesth Analg. 2008 Jan;106(1):114-9. 

38. Gokce G, Karboga H, Yildiz E, Ayan S, Gultekin Y. Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on apoptotic changes in contralateral testis following unilateral testicular torsion. Int Urol Nephrol. 2008;40(4):989-95. 

39. Ozdemir, O (Ozdemir, Oztuerk); Yildiz, E (Yildiz, Esin); Ayan, S (Ayan, Semih); Gul, E (Gul, Eylem)1; Gokce, G (Gokce, Goekhan); Yildiz, F (Yildiz, Fazilet)1; Koksal, B (Koksal, Binnur)1; Goze, F (Goze, Fahrettin); Gultekin, EY (Gultekin, E. Yener). Epigenetic alterations and oncogenes mutations in urinary bladder carcinomas.CHROMOSOME RESEARCH. 2009, Volume: 17 Supplement: 1 Pages: 171-171 

40. Eskicorapci SY, Türkeri L, Karabulut E, Cal C, Akpinar H, Baltaci S, Baykal K; Turkish Validation Study Group of Kattan Preoperative Nomogram, Kattan MW, Ozen H. Collaborators: Yildirim A, Yazici S, Divrik RT, Ozkardeş H, Koşan M, Kurtuluş FO, Büyükalpelli R, Mungan A, Lekili M, Sahin H, Günlüsoy B, Ayan S, Bozlu M. Validation of two preoperative Kattan nomograms predicting recurrence after radical prostatectomy for localized prostate cancer in Turkey: a multicenter study of the Urooncology Society. Urology. 2009 Dec;74(6):1289-95. 

41. Ozdemir O, Yildiz S, Ayan S, Gül E, Gokce G, Yildiz F, Koksal B. Promoter hypermethylation of tissue specific tumor supressor genes and point mutation in K-ras, c-myc proto-oncogenes in urinary (transitional cell) bladder carcinoma. Health. 2010; 2(8):850-856. 

42. Türkeri L, Tanıdır Y, Çal Ç, Özen H, Şahin H; Collaborators :Kaya C, Karaman İ, Şengör F, Alkibay T, Sözen S, Büyükalpelli R, Can C, Kuyumcuoğlu U, Albayrak S, Abay E, Soyupak B, Tansuğ Z, Fazlıoğlu A, Gültekin Y, Ayan S, Gümüş E, Lekili M, Dillioğlugil Ö, Özer G, Uygur C, Akpınar H. Comparison of the efficacy of single or double intravesical epirubicin instillation in the early postoperative period to prevent recurrences in non-muscle-invasive urothelial carcinoma of the bladder: prospective, randomized multicenter study. Urol Int. 2010;85(3):261-5. 

43. Kuzgunbay B, Yaycioglu O, Soyupak B, Atay Kayis A, Ayan S, Yavascaoglu I, Cal C, Beduk Y; Turkish Study Group of Public Awareness in Testicular Cancer Public awareness of testicular cancer and self-examination in Turkey: A multicenter study of Turkish Urooncology Society.Urol Oncol. 2011 Mar 22. Epub ahead of print] 

44. Biçer H, Korgali E, Gökçe G, Ayan S, Yıldırım S, Gültekin EY. Contractile responses of urinary bladder in an experimental model of chronic renal failure. Bosn J Basic Med Sci. 2012 Nov;12(4):219- 23. 

45. Yaycioglu O, Eskicorapci S, Karabulut E, Soyupak B, Gogus C, Divrik T, Turkeri L, Yazici S, Ozen H; Society of Urooncology Study Group for Kidney Cancer Prognosis. A preoperative prognostic model predicting recurrence-free survival for patients with kidney cancer. Jpn J Clin Oncol. 2013 Jan;43(1):63-8. 

46. Erden Y, Korgalı E, Dundar G, Ayan S, Gokce G, Yildirim S, Gultekin EY. In-vitro effects of PDE5 inhibitor and statin treatment on the contractile responses of experimental MetS rabbit's cavernous smooth muscle. Arch Ital Urol Androl. 2014 Mar 28;86(1):33-8.

Prof. Dr. Özgür Haki Yüksel - Specialist in Urology

Education and Specialization:

• Medical Degree: Ankara University Faculty of Medicine (2003)
• Residency in Urology: Haydarpaşa Numune Training and Research Hospital (2003-2008)
• Advanced Training: Clinical observership at the University of Michigan, Department of Urology, Ann Arbor, MI, USA under Prof. J. Stuart Wolf (2015)

Professional Experience:

• 2003-2008: Urology Residency at Haydarpaşa Numune Training and Research Hospital
• 2009-2010: Military Service
• 2010-2018: Urology Specialist at Fatih Sultan Mehmet Training and Research Hospital
• 2018-Present: Professor and Urology Specialist at VM Medical Park Pendik Hospital
• 2018-Present: Faculty Member at Bahçeşehir University Faculty of Medicine, Department of Urology

Areas of Expertise:

• Urological Oncology
• Endourology (Laparoscopy, Robotic Surgery)
• Stone Diseases
• Urogynecology (Urinary Incontinence)
• Andrology (Infertility)

Research and Publications: Prof. Dr. Yüksel has contributed to 12 national and 34 international publications, including editorials, case reports, reviews, and original articles. He has also presented 16 international and 30 national conference papers and contributed to chapters in two national books.

Certifications and Awards:

• FEBU Board Certification, recognized across European countries for urology specialization
• Numerous certifications from national and international courses and congresses, including the European Board of Urology oral and written exams

Professional Memberships:

• Turkish Urology Association
• European Urology Association (EAU)

Professor Jan Fichtner is the head of the urology clinic and one of the best specialists in Germany in urological operations and treatment of benign prostate diseases according to Focus.

• President of the German Urological Society (DGU) and member of many specialist associations;
• winner of 5 awards, including the American Urological Association Prize;
• author of 152 scientific articles, 28 book publications.

Dr. Antonio Alcaraz is a Spanish uro-oncologist and transplantologist with over 30 years of experience and 500 successful operations, specializing in the treatment of prostate cancer, kidney, bladder, and other urogenital system pathologies using minimally invasive and robotic systems, as well as congenital pathologies in children. He is a member of several prestigious urological societies.